Bifidobacterium lactis 관련 Immune Aging (Immunosenescence)

Meta-analysis demonstrates short-term Bifidobacterium lactis supplementation may enhance NK cell activity and polymorphonuclear phagocytic capacity in healthy elderly adults. Supports balanced Th1/Th2 immune response in aging populations.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dbifidobacterium\u002Dlactis\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Key Study Findings

Other

Bifidobacterium lactis BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization.

Dose: 12 g vs: None Outcome: None 효과: None None

대상 집단: None

Randomized Controlled Trial n=27 3 weeks

Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related …

Dose: L. rhamnosus HN001 or B. lactis HN019 vs: Low fat milk (control) Outcome: NK cell activity and lymphocyte counts 효과: Enhanced NK cytotoxicity with both probiotics None

대상 집단: Elderly subjects (63-84 years)

Key Statistics

연구

300

참여자

↑

Positive

등급

Referenced Papers

Bifidobacterium lactis BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization. Other

Journal of immunology … 2019 18 인용

Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. CCT

Journal of clinical … 2001 337 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:: 1-10 billion CFU/day

상한량: No established UL

연구에서 사용된 용량

용량	기간	효과	N
12 g	--	Mixed	--
L. rhamnosus HN001 or B. lactis HN019	3 weeks	Positive	27

권장 복용 시간: With meals or on empty stomach; consistent daily use

Safety & Side Effects

보고된 부작용

⚠ Mild bloating and gas (usually transient)
⚠ Generally very well tolerated

알려진 상호작용

● Antibiotics (may reduce probiotic effectiveness; space doses 2+ hours apart)

일일 최대 섭취 허용량: No established UL

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Bifidobacterium lactis help with Immune Aging (Immunosenescence)?

Based on 5 studies with 300 participants, there is moderate evidence from clinical studies that Bifidobacterium lactis may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).

How much Bifidobacterium lactis should I take for Immune Aging (Immunosenescence)?

Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Bifidobacterium lactis?

Reported side effects may include Mild bloating and gas (usually transient), Generally very well tolerated. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Bifidobacterium lactis and Immune Aging (Immunosenescence)?

We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

한눈에 보기

Evidence Strength72%

High confidence

연구 분석

RCT (0)Meta (0)Other (5)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: Immune Aging (Immunosenescence)

자세히 알아보기

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.